Teladoc Health Reports First Quarter 2022 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Teladoc (TDOC) Q1 Revenue Misses Consensus, Offers Guidance
April 27, 2022 4:10 PM EDTTeladoc (NYSE: TDOC) reported Q1 EPS of ($41.58), may not compare to the analyst estimate of ($0.56). Revenue for the quarter came in at $565.4 million versus the consensus estimate of $568.8 million.
Net loss per share of $41.58, primarily driven by non-cash goodwill impairment charge of $6.6... More


